nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

24.04.2018 | Gynecologic Oncology

miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2

verfasst von: Cuilan Wang, Bo Liu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to investigate the effect of miR-101-3p on autophagy in endometrial carcinoma (EC) cells and the connection between miR-101-3p and EZH2.

Methods

The expression levels of miRNAs were analyzed by microarray. The expression level of autophagy related proteins was measured by western blot. The mRNA expression level of beclin-1 was determined by qRT-PCR. Autophagy in EC cells was traced by GFP-LC3 fusion protein and observed by fluorescence microscopy. The number of autophagic vacuoles was determined by transmission electron microscopy (TEM). A luciferase reporter assay was utilized to assess the target relationship between miR-101-3p and EZH2.

Results

The expression level of miR-101-3p in EC tissues was lower than in normal tissues. miR-101-3p upregulated the expression levels of the autophagy-related proteins LC3-II and beclin-1 in EC cells in a time- and dose-dependent manner. Overexpression of miR-101-3p and silencing of EZH2 both promoted autophagy in EC cells. Luciferase reporter assays verified that miR-101-3p inhibited EZH2 expression by binding to its 3’-UTR region.

Conclusion

miR-101-3p promoted autophagy in EC cells by downregulating the expression of EZH2, and it induced autophagy in EC cells by suppressing EZH2 expression. Inhibition of miR-101-3p could reduce its autophagy induction effect on EC cells.

Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E (2016) Endometrial cancer. Lancet 387:1094–1108CrossRefPubMed

Eritja N, Chen BJ, Rodriguez-Barrueco R et al (2017) Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer. Autophagy 13:608–624CrossRefPubMedPubMedCentral

Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607–2618CrossRefPubMedPubMedCentral

Tangjitgamol S, See HT, Kavanagh J (2011) Adjuvant chemotherapy for endometrial cancer. Int J Gynecol Cancer 21:885–895CrossRefPubMed

Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482:347–355CrossRefPubMedPubMedCentral

Konno Y, Dong P, Xiong Y et al (2014) MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 5:6049–6062CrossRefPubMedPubMedCentral

Sheng Y, Ding S, Chen K et al (2014) Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Biochem Cell Biol 92:152–162CrossRefPubMed

Wu J, Tao Y, Shang A et al (2017) Effect of the interaction between MiR-200b-3p and DNMT3A on cartilage cells of osteoarthritis patients. J Cell Mol Med 21:2308–2316CrossRefPubMedPubMedCentral

Hiroki E, Suzuki F, Akahira J et al (2012) MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. Int J Cancer 131:E395–E404CrossRefPubMed

10.

Hiroki E, Akahira J, Suzuki F et al (2010) Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 101:241–249CrossRefPubMed

11.

Yoo KH, Hennighausen L (2012) EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8:59–65CrossRefPubMed

12.

Huang D, Wang X, Zhuang C et al (2016) Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma. Oncol Rep 35:1083–1090CrossRefPubMed

13.

Xu L, Beckebaum S, Iacob S et al (2014) MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J Hepatol 60:590–598CrossRefPubMed

14.

Lei Q, Shen F, Wu J, Zhang W, Wang J, Zhang L (2014) MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. Oncol Rep 32:261–269CrossRefPubMed

15.

Lin C, Huang F, Li QZ, Zhang YJ (2014) miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. Int J Clin Exp Pathol 7:6543–6550PubMedPubMedCentral

16.

Luo C, Merz PR, Chen Y et al (2013) MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Cancer Lett 341:240–247CrossRefPubMed

17.

Peng Z, Zhang Y (2017) Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA101. Mol Med Rep 15:957–962CrossRefPubMed

18.

Zhang K, Zhang Y, Ren K, Zhao G, Yan K, Ma B (2014) MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression. Oncol Rep 32:2143–2149CrossRefPubMed

19.

Liu L, Guo J, Yu L et al (2014) miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer. Tumour Biol J Int Soc Oncodev Biol Med 35:12619–12626CrossRef

20.

Jia N, Li Q, Tao X, Wang J, Hua K, Feng W (2014) Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma. Oncol Lett 8:2049–2054CrossRefPubMedPubMedCentral

21.

Eskander RN, Ji T, Huynh B, Wardeh R, Randall LM, Hoang B (2013) Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Int J Gynecol Cancer 23:997–1005CrossRefPubMedPubMedCentral

22.

Wu D, Jiang H, Chen S, Zhang H (2015) Inhibition of microRNA-101 attenuates hypoxia/reoxygenation induced apoptosis through induction of autophagy in H9c2 cardiomyocytes. Mol Med Rep 11:3988–3994CrossRefPubMed

23.

Petersen M, Hofius D, Andersen SU (2014) Signaling unmasked: autophagy and catalase promote programmed cell death. Autophagy 10:520–521CrossRefPubMedPubMedCentral

24.

Frankel LB, Wen J, Lees M et al (2011) microRNA-101 is a potent inhibitor of autophagy. EMBO J 30:4628–4641CrossRefPubMedPubMedCentral

25.

Guo J, Huang X, Wang H, Yang H (2015) Celastrol induces autophagy by targeting AR/miR-101 in prostate cancer cells. PLoS ONE 10:e0140745CrossRefPubMedPubMedCentral

26.

Wei FZ, Cao Z, Wang X et al (2015) Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway. Autophagy 11:2309–2322CrossRefPubMed

27.

He XP, Shao Y, Li XL et al (2012) Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J 279:4201–4212CrossRefPubMed

28.

Strillacci A, Valerii MC, Sansone P et al (2013) Loss of miR-101 expression promotes Wnt/beta-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol 229:379–389CrossRefPubMed

29.

Zhang J, Han C, Zhu H, Song K, Wu T (2013) miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). Am J Pathol 182:1629–1639CrossRefPubMedPubMedCentral

30.

Wu X, Zhou J, Wu Z et al (2017) miR-101-3p suppresses HOX transcript antisense RNA (HOTAIR)-induced proliferation and invasion through directly targeting SRF in gastric carcinoma cells. Oncol Res 25:1383–1390CrossRefPubMed

31.

Xu Y, An Y, Wang Y et al (2013) miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep 29:2019–2024CrossRefPubMed

32.

Huang D, Qiu S, Ge R et al (2015) miR-340 suppresses glioblastoma multiforme. Oncotarget 6:9257–9270PubMedPubMedCentral

33.

Zhou J, Roh JW, Bandyopadhyay S et al (2013) Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma. Gynecol Oncol 128:344–348CrossRefPubMed

34.

Bachmann IM, Halvorsen OJ, Collett K et al (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24:268–273CrossRefPubMed

35.

Liu TP, Lo HL, Wei LS, Hsiao HH, Yang PM (2015) S-Adenosyl-l-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells. Anticancer Drugs 26:139–147CrossRefPubMed

36.

Sun Y, Jin L, Liu JH, Sui YX, Han LL, Shen XL (2016) Interfering EZH2 expression reverses the cisplatin resistance in human ovarian cancer by inhibiting autophagy. Cancer Biother Radiophar 31:246–252CrossRef

Titel: miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2
verfasst von: Cuilan Wang
Bo Liu
Publikationsdatum: 24.04.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2018
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-018-4768-7

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2

Abstract

Objective

Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Female genital tract congenital malformations and the applicability of the ESHRE/ESGE classification: a systematic retrospective analysis of 920 patients

Can ebselen prevent cisplatin-induced ovarian damage?

Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity—a retrospective study of 1214 breast cancer patients

Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management

Pelvic floor muscle activity during jumps in continent and incontinent women: an exploratory study

Influence of training level on cervical cone size and resection margin status at conization: a retrospective study

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie